
 |
| Marfan Syndrome |
 |
 |
|
|
United States |
|
Comprehensive guide to this connective tissue disease.
|
 |
|
|
|
| Related Site |
 |
 |
Neck Pillow for support and neck pain relief : The Cervical Traction Neck Pillow is designed for neck pain relief, improved posture, and neck support. Neck traction devices, other neck support pillows and neck exercises are also available.
National Marfan Foundation : Providing accurate and timely information about the disorder to patients, family members and physicians.
American Behcet's Disease Association : Concise information about Behcet's Disease, including diagnostic criteria and treatment. E-mail list available for patients.
Fibromyalgia and Chronic Fatigue Syndrome Relief : Information and details on these conditions with free downloadable report.
New York Support Network, Inc. (NYSN) : Encourages the preservation and development of CFIDS and fibromyalgia syndrome support groups in New York State.
Fibromyalgia Treatment and Research News : Fibromyalgia and chronic fatigue syndrome research articles, treatment information, support groups, free email bulletins...
The Mystery of Akhenaten: Genetics or Aesthetics? : A history of the pharoah along with theories applied to what he may have had, including Marfan's.
Lupus Now : A magazine for people with lupus and their families, lupus health professionals and researchers. Published by the Lupus Foundation of America.
Bursitis : Information from the Mayo Clinic.
ProHealthNetwork.com - Lupus : Read the latest Lupus treatment information and news. Post messages to other visitors who have Lupus in our chat room and message boards.
|
|
|
 |
 |
 |
Virus Unlikely to Cause Chronic Fatigue Syndrome (HealthDay)
HealthDay - THURSDAY, Feb. 25 (HealthDay News) -- A new study adds to
evidence that chronic fatigue syndrome doesn't have anything to do with
xenotropic murine leukemia virus-related virus (XMRV), but the researchers
point out that there's a caveat regarding American patients. |
 |
Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval for Tykerb (lapatinib) to include
postmenopausal women with hormone- and HER2-positive advanced breast
cancer who require hormone therapy. |
|
|
 |